Thursday, February 07, 2019 11:15:00 AM
No, CVSI does not and will not ever trade on a real stock exchange. Ignore the heretofore unseen 100’s if not 1,000’s opining of an “uplist” they’re a laugh, It didn’t happen then and it’s not happening in the future. It was asked, “is that green I see??” The answer is YES. Amazingly coincidental, I missed today’s bottom (to date) by $.01 but CVSI immediately shot up green once I got back in for my 18th run. No one is happier then me at seeing my predicted run to green after buying again although I only got 11,000 shares of CVSI this time. 1,000 at $4.85 yesterday and 10,000 at $4.69 today. I expect to sell at between $5.25 and $5.50 by Monday perhaps Tuesday or Wednesday. CVSI moves quickly when it moves then remains stagnant for excruciatingly long periods.
NASDAQ themselves have an article on the web about potential OTC Companies moving to their exchange. Unfortunately of course CVSI is not included amongst them and never will be. The article begins;
Do you think penny stocks are best left to amateur traders who don't understand that cheap stocks are cheap for a reason? It's not an entirely unfair assessment. Many of these young (and doomed companies) are the beneficiaries of great sales pitches, but their investors often end up suffering buyer's remorse.
It can be found at the following URL:
https://www.nasdaq.com/article/4-penny-stocks-to-own-for-2018-cm960529
In the meanwhile I’m awaiting that $5.25 to $5.50 to sell these 11,000 shares of CVSI or preferably $4.50 to buy 39,000 more.
I’m ROTFLMAO AND OTFL at the 1,000’s Of predictions of CVSI trading on a real stock exchange, those are a laugh. CVSI trades between market makers down here on the OTC and always will, unless they get halted.
Minds are like parachutes: they only function when they're open
Recent CVSI News
- Form 8-K - Current report • Edgar (US Regulatory) • 12/12/2023 02:36:49 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 08:21:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2023 01:32:15 PM
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM